Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response (NCT04142177) | Clinical Trial Compass
RecruitingNot Applicable
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
United States2,529 participantsStarted 2022-06-13
Plain-language summary
VETERANS ONLY. Chronic low back pain (cLBP) is common. Most Americans will have at least one episode of low back pain in their lifetimes. Approximately 50% of all US Veterans have chronic pain, and CLBP is the most common type of pain in this population. This study will use a sequential randomized, pragmatic, 2-step comparative effectiveness study design. The main goal is to identify the best approach for treating cLBP using commonly recommended non-surgical and non-pharmacological options. The first step compares continued care and active monitoring (CCAM) to internet-based pain self-management (Pain EASE) and an enhanced physical therapy intervention that combines Pain EASE with tailored exercise and physical activity. Patients who do not have a significant decrease in pain interference (a functional outcome) in Step 1 and those desiring additional treatment will be randomized in Step 2 to yoga, spinal manipulation therapy (SMT), or therapist-delivered cognitive behavioral therapy (CBT). Participants proceeding to randomization in Step 2 will be allowed to exclude up to one of the three Step 2 treatments based on their preferences. The investigators' primary hypothesis for the first treatment step is that an enhanced physical therapy intervention that combines pain self-management education with a tailored exercise program will reduce pain interference greater than internet-based pain self-management alone or CCAM in Veterans with cLBP. The primary outcome is change in pain interference at 3 months, measured using the Brief Pain Inventory (BPI) pain interference subscale. Study participants will be followed for one year after initiation of their final study treatments to assess the durability of treatment effects. The study plans to randomize 2529 patients across 20 centers.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Low back pain
✓. present for at least 6 months,
✓. present most days or everyday,
✓. interferes the most with activities considering all of the places where the patient experiences pain;
✓. Pain, Enjoyment, General Activity (PEG) score of 4 or greater;
✓. Veteran age 18 years or older, either sex, any racial or ethnic background;
✓. Able to comprehend and willing to sign the study informed consent form;
✓. Able and willing to attend in-person treatment sessions;
Exclusion criteria
✕. Currently enrolled in any other interventional study unless exempted by CSP;
✕. Acute or chronic illness that would prevent the Veteran from receiving study treatments offered (e.g., uncontrolled hypertension, recent myocardial infarction within the last 6 months, unstable angina, acute congestive heart failure);
✕. Neurological impairment related to disease of the spine or other causes preventing participation in any of the treatment modalities under study;
✕. Current or recent (last 3 months) treatment involving Cognitive Behavioral Therapy, Spinal manipulation therapy, or Yoga;
✕. Current severe alcohol or substance abuse use disorder;
✕. Severe psychiatric illness (e.g. current psychosis, current suicidal ideation, or psychiatric illness requiring hospitalization within the last 6 months);
✕. Back surgery within the last 6 months, or undergoing evaluation for back surgery or planned back surgery;
✕. Cognitive or severe hearing or visual impairment preventing participation in treatment options or outcome measure assessments;